Socioeconomic status, not race/ethnicity, contributes to variation in the prevalence of erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

The Journal of Sexual Medicine
Varant KupelianJohn B McKinlay

Abstract

Few population-based studies have assessed variations in the burden of erectile dysfunction (ED) by race/ethnicity. To estimate prevalence rates of ED by race/ethnicity and determine the contribution of behavioral risk factors, chronic illnesses, and socioeconomic factors to potential race/ethnic differences in ED. The Boston Area Community Health (BACH) Survey is a study of urologic symptoms in a racially and ethnically diverse population. BACH used a multistage stratified random sample to recruit 2,301 men aged 30-79 years from the city of Boston. Self-reported race/ethnicity was defined as Black, Hispanic, and White. Socioeconomic status (SES) was defined as a combination of education and household income. ED assessed using the 5-item International Index of Erectile Function (IIEF-5). IIEF-5 scores were used both as a continuous variable and dichotomized as </=16 vs. >/=17. Overall prevalence of ED (defined as an IIEF-5 score </=16) was 20.7% with higher prevalence observed among both Black men (24.9%) and Hispanic men (25.3%) compared to White men (18.1%). Increased odds of ED were observed for both Black and Hispanic men after adjusting for age, comorbid conditions (cardiovascular disease, diabetes, depression), and behavi...Continue Reading

References

Feb 1, 1993·Journal of Clinical Epidemiology·R A WashburnC A Janney
Feb 18, 1999·JAMA : the Journal of the American Medical Association·E O LaumannR C Rosen
Oct 16, 1999·The Journal of Clinical Endocrinology and Metabolism·A VermeulenJ M Kaufman
Dec 8, 2004·European Urology·Anton PonholzerStephan Madersbacher
Jul 1, 2005·Journal of General Internal Medicine·Amy B O'DonnellJohn B McKinlay
Jan 25, 2006·Archives of Internal Medicine·Christopher S SaigalUNKNOWN Urologic Diseases in America Project
Aug 17, 2006·The Journal of Clinical Endocrinology and Metabolism·Heather J LitmanJohn B McKinlay
Feb 6, 2007·The American Journal of Medicine·Elizabeth SelvinElizabeth A Platz
Jul 25, 2007·The Journal of Sexual Medicine·Kew-Kim ChewKonrad Jamrozik
Jan 16, 2008·The Journal of Sexual Medicine·Kew-Kim ChewBronwyn Stuckey

❮ Previous
Next ❯

Citations

Jun 18, 2010·International Journal of Impotence Research·A C K LeeT H Lam
Dec 12, 2012·International Journal of Epidemiology·Rebecca S PiccoloJohn B McKinlay
Nov 6, 2009·The Journal of Sexual Medicine·Fernando Gonini Martins, Carmita Helena Najjar Abdo
Nov 5, 2010·The Journal of Sexual Medicine·Brian DodgeJ Dennis Fortenberry
Oct 3, 2009·The Journal of Sexual Medicine·James F SmithStephen K Van den Eeden
Oct 3, 2009·The Journal of Sexual Medicine·Rany Shamloul
Jan 16, 2009·The Journal of Sexual Medicine·Kew-Kim ChewKonrad Jamrozik
Jan 12, 2010·The Journal of Sexual Medicine·Ajit AvasthiP Kulhara
Oct 24, 2012·The Journal of Sexual Medicine·G M Monawar HosainDrew A Helmer
Dec 19, 2008·The Journal of Sexual Medicine·Annamaria Giraldi
Mar 25, 2015·The Journal of Sexual Medicine·Ross M SimonAdriana C Vidal
Aug 29, 2012·Dermato-endocrinology·Marc Sorenson, William B Grant
Nov 12, 2016·Journal of Diabetes and Its Complications·Shinya FurukawaYoshihiro Miyake
Jan 10, 2013·American Journal of Men's Health·G M Monawar HosainDrew A Helmer
Jul 4, 2019·BJU International·Anna KesslerMieke Van Hemelrijck
Apr 15, 2020·Current Vascular Pharmacology·Konstantinos ImprialosMichael Doumas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.